• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MRI 影像特征:肝细胞癌、肝内胆管细胞癌及联合肿瘤的 LI-RADS 2014 版诊断

Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014.

机构信息

Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.

Department of Radiology, Hospital Sírio-Libanês, Sao Paulo, Brazil.

出版信息

Abdom Radiol (NY). 2018 Jan;43(1):169-178. doi: 10.1007/s00261-017-1261-x.

DOI:10.1007/s00261-017-1261-x
PMID:28765978
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6598685/
Abstract

PURPOSE

To evaluate the prevalence of major and ancillary imaging features from liver imaging reporting and data systems (LI-RADS) version 2014 and their interreader agreement when comparing hepatocellular carcinoma (HCC) to intrahepatic cholangiocarcinoma (ICC) and combined tumor (cHCC-CC).

METHODS

The Institutional Review Board approved this HIPAA-compliant retrospective study and waived the requirement for patients' informed consent. Patients with resected HCC (n = 51), ICC (n = 40), and cHCC-CC (n = 11) and available pre-operative contrast-enhanced MRI were included from 2000 to 2015. Imaging features and final LI-RADS category were evaluated by four radiologists. Imaging features were compared by Fisher's exact test and interreader agreements were assessed by κ statistics.

RESULTS

None of the features were unique to either HCC or non-HCC. Imaging features that were significantly more common among HCC compared to ICC and cHCC-CC included washout (76%-78% vs. 10%-35%, p < 0.001), capsule (55%-71% vs. 16%-49%, p < 0.05), and intralesional fat (27%-52% vs. 2%-12%, p < 0.002). Features that were more common among ICC and cHCC-CC included peripheral arterial phase hyperenhancement (40%-64% vs. 10%-14%, p < 0.001) and progressive central enhancement (65%-82% vs. 14%-25%, p < 0.001). The interreader agreement was moderate for each of these imaging features (κ = 0.41-0.55). Moderate agreement was also achieved in the assignment of LR-M (κ = 0.53), with an overall sensitivity and specificity for non-HCC malignancy of 86.3% and 78.4%, respectively.

CONCLUSION

HCC and non-HCC show significant differences in the prevalence of imaging features defined by LI-RADS, and are identified by radiologists with moderate interreader agreement. Using LI-RADS, radiologists also achieved moderate interreader agreement in the assignment of the LR-M category.

摘要

目的

评估 2014 版肝脏影像报告和数据系统(LI-RADS)的主要和辅助影像学特征的流行程度,并比较肝细胞癌(HCC)与肝内胆管细胞癌(ICC)和混合型肿瘤(cHCC-CC)之间的读者间一致性。

方法

本机构审查委员会批准了这项符合 HIPAA 标准的回顾性研究,并豁免了患者知情同意的要求。该研究纳入了 2000 年至 2015 年间接受过手术切除的 HCC(n=51)、ICC(n=40)和 cHCC-CC(n=11)患者,且均有术前增强 MRI 资料。由四位放射科医生评估影像学特征和最终的 LI-RADS 分类。采用 Fisher 确切检验比较影像学特征,采用κ 统计评估读者间的一致性。

结果

没有任何特征是 HCC 或非 HCC 所特有的。与 HCC 相比,ICC 和 cHCC-CC 更常见的影像学特征包括:洗脱(76%-78%比 10%-35%,p<0.001)、包膜(55%-71%比 16%-49%,p<0.05)和瘤内脂肪(27%-52%比 2%-12%,p<0.002)。ICC 和 cHCC-CC 更常见的特征包括:外周动脉期强化(40%-64%比 10%-14%,p<0.001)和渐进性中央强化(65%-82%比 14%-25%,p<0.001)。这些影像学特征的读者间一致性为中等(κ=0.41-0.55)。LR-M 的赋值也达到了中等一致性(κ=0.53),非 HCC 恶性肿瘤的总灵敏度和特异性分别为 86.3%和 78.4%。

结论

LI-RADS 定义的 HCC 和非 HCC 的影像学特征存在显著差异,放射科医生可以通过这些特征进行识别,并且读者间的一致性为中等。放射科医生使用 LI-RADS 对 LR-M 类别进行赋值,也获得了中等的读者间一致性。

相似文献

1
Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014.MRI 影像特征:肝细胞癌、肝内胆管细胞癌及联合肿瘤的 LI-RADS 2014 版诊断
Abdom Radiol (NY). 2018 Jan;43(1):169-178. doi: 10.1007/s00261-017-1261-x.
2
MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.MRI 特征在肝细胞癌-胆管细胞癌与肿块型肝内胆管细胞癌的对比。
Cancer Imaging. 2018 Feb 27;18(1):8. doi: 10.1186/s40644-018-0142-z.
3
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.在一项多中心回顾性研究中,1006 个结节的对比超声 LI-RADS LR-5 可识别肝硬化中的肝细胞癌。
J Hepatol. 2018 Mar;68(3):485-492. doi: 10.1016/j.jhep.2017.11.007. Epub 2017 Nov 11.
4
Diagnostic performance of LI-RADS version 2018 in differentiating hepatocellular carcinoma from other hepatic malignancies in patients with hepatitis B virus infection.LI-RADS 版本 2018 诊断性能在乙型肝炎病毒感染患者中区分肝细胞癌与其他肝脏恶性肿瘤。
Bosn J Basic Med Sci. 2020 Aug 3;20(3):401-410. doi: 10.17305/bjbms.2019.4576.
5
Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient's survival?肝细胞癌-胆管细胞癌混合型:我们能否使用增强超声肝脏影像报告与数据系统(LI-RADS)来预测患者的生存情况?
Eur Radiol. 2021 Aug;31(8):6397-6405. doi: 10.1007/s00330-020-07656-1. Epub 2021 Jan 25.
6
Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS.高危人群肝细胞癌无创诊断标准化算法的观察者间和模态间一致性:CEUS-LI-RADS 与 MRI-LI-RADS。
Eur Radiol. 2018 Oct;28(10):4254-4264. doi: 10.1007/s00330-018-5379-1. Epub 2018 Apr 19.
7
How to utilize LR-M features of the LI-RADS to improve the diagnosis of combined hepatocellular-cholangiocarcinoma on gadoxetate-enhanced MRI?如何利用 LI-RADS 的 LR-M 特征提高钆塞酸增强 MRI 诊断混合细胞型肝癌?
Eur Radiol. 2019 May;29(5):2408-2416. doi: 10.1007/s00330-018-5893-1. Epub 2018 Dec 14.
8
LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.肝脏影像报告和数据系统-超声造影 - 关于高危人群肝细胞癌诊断的超声造影算法提案
Ultraschall Med. 2016 Dec;37(6):627-634. doi: 10.1055/s-0042-112221. Epub 2016 Aug 3.
9
Diagnostic accuracy of liver imaging reporting and data system (LI-RADS) v2014 for intrahepatic mass-forming cholangiocarcinomas in patients with chronic liver disease on gadoxetic acid-enhanced MRI.肝脏影像报告和数据系统(LI-RADS)v2014对慢性肝病患者钆塞酸二钠增强MRI检查中肝内肿块型胆管癌的诊断准确性
J Magn Reson Imaging. 2016 Nov;44(5):1330-1338. doi: 10.1002/jmri.25287. Epub 2016 Apr 18.
10
LI-RADS Version 2018 Targetoid Appearances on Gadoxetic Acid-Enhanced MRI: Interobserver Agreement and Diagnostic Performance for the Differentiation of HCC and Non-HCC Malignancy.LI-RADS 版本 2018 钆塞酸增强 MRI 上的靶样外观:鉴别 HCC 和非 HCC 恶性肿瘤的观察者间协议和诊断性能。
AJR Am J Roentgenol. 2022 Sep;219(3):421-432. doi: 10.2214/AJR.22.27380. Epub 2022 Mar 23.

引用本文的文献

1
Comparison of Apparent Diffusion Coefficient Values on Diffusion-Weighted MRI for Differentiating Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.磁共振扩散加权成像表观扩散系数值在肝细胞癌与肝内胆管癌鉴别诊断中的比较
Diagnostics (Basel). 2025 Jul 24;15(15):1861. doi: 10.3390/diagnostics15151861.
2
Synchronous Hepatocellular and Intrahepatic Cholangiocellular Carcinoma With Predominant Ductal Plate Malformation Pattern. A Case Report and Review of the Literature.以导管板畸形模式为主的同步性肝细胞癌和肝内胆管细胞癌。病例报告及文献复习
Cancer Rep (Hoboken). 2025 Feb;8(2):e70085. doi: 10.1002/cnr2.70085.
3

本文引用的文献

1
Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma.肝细胞癌切除术后的实际10年生存者
Ann Surg Oncol. 2017 May;24(5):1358-1366. doi: 10.1245/s10434-016-5713-2. Epub 2016 Dec 5.
2
Reliability, Validity, and Reader Acceptance of LI-RADS-An In-depth Analysis.肝脏影像报告和数据系统(LI-RADS)的可靠性、有效性及读者接受度——深入分析
Acad Radiol. 2016 Sep;23(9):1145-53. doi: 10.1016/j.acra.2016.03.014. Epub 2016 May 9.
3
Hepatocellular carcinoma.肝细胞癌。
Performance of LI-RADS category 5 vs combined categories 4 and 5: a systemic review and meta-analysis.
LI-RADS 类别 5 与类别 4 和 5 联合的表现:系统评价和荟萃分析。
Eur Radiol. 2024 Nov;34(11):7025-7040. doi: 10.1007/s00330-024-10813-5. Epub 2024 May 29.
4
Combined hepatocellular-cholangiocarcinoma: from genesis to molecular pathways and therapeutic strategies.混合型肝细胞癌:从发生机制到分子通路和治疗策略。
J Cancer Res Clin Oncol. 2024 May 23;150(5):270. doi: 10.1007/s00432-024-05781-8.
5
Imaged periductal infiltration: Diagnostic and prognostic role in intrahepatic mass-forming cholangiocarcinoma.影像显示的导管周围浸润:在肝内肿块型胆管癌中的诊断及预后作用
Eur J Radiol Open. 2024 Feb 16;12:100554. doi: 10.1016/j.ejro.2024.100554. eCollection 2024 Jun.
6
Evidence Supporting Diagnostic Value of Liver Imaging Reporting and Data System for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.支持肝脏影像报告和数据系统对基于CT和MR成像的肝细胞癌诊断的诊断价值的证据:一项系统评价和荟萃分析。
J Biomed Phys Eng. 2024 Feb 1;14(1):5-20. doi: 10.31661/jbpe.v0i0.2211-1562. eCollection 2024 Feb.
7
Computerized Diagnosis of Liver Tumors From CT Scans Using a Deep Neural Network Approach.基于深度学习神经网络的 CT 扫描肝脏肿瘤计算机辅助诊断。
IEEE J Biomed Health Inform. 2023 May;27(5):2456-2464. doi: 10.1109/JBHI.2023.3248489. Epub 2023 May 4.
8
Update on the Use of Artificial Intelligence in Hepatobiliary MR Imaging.人工智能在肝胆磁共振成像中的应用进展。
Magn Reson Med Sci. 2023 Apr 1;22(2):147-156. doi: 10.2463/mrms.rev.2022-0102. Epub 2023 Jan 26.
9
HCC or Something Else? Frequency of Various Benign and Malignant Etiologies in Cirrhotic Patients with Newly Detected Focal Liver Lesions in Relation to Different Clinical and Sonographic Parameters.肝细胞癌还是其他病症?肝硬化患者新发现局灶性肝病变的各种良性和恶性病因的发生率与不同临床及超声参数的关系
Diagnostics (Basel). 2022 Aug 28;12(9):2079. doi: 10.3390/diagnostics12092079.
10
MRI-Based Radiomics Models to Discriminate Hepatocellular Carcinoma and Non-Hepatocellular Carcinoma in LR-M According to LI-RADS Version 2018.基于MRI的影像组学模型,根据LI-RADS 2018版鉴别低风险(LR-M)肝细胞癌和非肝细胞癌。
Diagnostics (Basel). 2022 Apr 21;12(5):1043. doi: 10.3390/diagnostics12051043.
Nat Rev Dis Primers. 2016 Apr 14;2:16018. doi: 10.1038/nrdp.2016.18.
4
Diagnostic accuracy of liver imaging reporting and data system (LI-RADS) v2014 for intrahepatic mass-forming cholangiocarcinomas in patients with chronic liver disease on gadoxetic acid-enhanced MRI.肝脏影像报告和数据系统(LI-RADS)v2014对慢性肝病患者钆塞酸二钠增强MRI检查中肝内肿块型胆管癌的诊断准确性
J Magn Reson Imaging. 2016 Nov;44(5):1330-1338. doi: 10.1002/jmri.25287. Epub 2016 Apr 18.
5
Small Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in Cirrhotic Livers May Share Similar Enhancement Patterns at Multiphase Dynamic MR Imaging.肝硬化小型肝内胆管细胞癌和肝细胞癌在多期动态磁共振成像上可能具有相似的强化模式。
Radiology. 2016 Oct;281(1):150-7. doi: 10.1148/radiol.2016151205. Epub 2016 Apr 14.
6
Imaging Features of Biphenotypic Primary Liver Carcinoma (Hepatocholangiocarcinoma) and the Potential to Mimic Hepatocellular Carcinoma: LI-RADS Analysis of CT and MRI Features in 61 Cases.双表型原发性肝癌(肝内胆管癌)的影像学特征及模仿肝细胞癌的可能性:61例CT和MRI特征的LI-RADS分析
AJR Am J Roentgenol. 2016 Jul;207(1):25-31. doi: 10.2214/AJR.15.14997. Epub 2016 Feb 11.
7
Cancer statistics, 2016.癌症统计数据,2016 年。
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
8
Identification of Imaging Predictors Discriminating Different Primary Liver Tumours in Patients with Chronic Liver Disease on Gadoxetic Acid-enhanced MRI: a Classification Tree Analysis.钆塞酸二钠增强MRI鉴别慢性肝病患者不同原发性肝肿瘤的影像预测指标:分类树分析
Eur Radiol. 2016 Sep;26(9):3102-11. doi: 10.1007/s00330-015-4136-y. Epub 2015 Dec 3.
9
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
10
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.全球、地区和国家按年龄、性别划分的 240 种死因的全死因和特定死因死亡率,1990-2013 年:2013 年全球疾病负担研究的系统分析。
Lancet. 2015 Jan 10;385(9963):117-71. doi: 10.1016/S0140-6736(14)61682-2. Epub 2014 Dec 18.